HOME >> BIOLOGY >> NEWS
Moderate alcohol consumption may reduce your chances of a heart attack

  • 1 of every 2 men and 1 of every 3 women age 40 or less will develop coronary heart disease (CHD).

  • CHD is the number one killer of both men and women in the U.S.

  • High levels of a clotting protein called fibrinogen may contribute to CHD.

  • Moderate alcohol consumption may decrease fibrinogen levels, thereby decreasing harmful clotting.

Heart disease is the number one killer of Americans, according to the National Heart, Lung and Blood Institute of the National Institutes of Health. The most common form of heart disease is coronary heart disease (CHD), which occurs when the coronary arteries become narrowed or clogged and cannot supply enough oxygen-rich blood to the heart. High amounts of a clotting protein called fibrinogen - levels of which tend to increase as people grow older - are associated with coronary artery, cerebral vascular and peripheral vascular diseases. However, a recent study published in the December issue of Alcoholism: Clinical & Experimental Research shows that moderate consumption of alcohol may decrease production and circulating levels of fibrinogen by up to 20 percent.

"This is a very significant finding," said Gerald M. Fuller, senior study author and professor of cell biology at the University of Alabama at Birmingham. "Anything that we can take naturally that reduces high circulating levels of fibrinogen by 15 to 20 percent could have a big impact in terms of coronary artery diseases." He added that "epidemiological studies have overwhelmingly demonstrated the importance of fibrinogen as a risk factor, and diminishing it by a small amount can have a truly profound effect."

Researchers studied the impact of daily consumption of moderate amounts of alcohol - equivalent to roughly two drinks per day - at two levels: using an animal model (in vivo) and liver-derived cells (in vitro). The animal-study findings demonstrated an 18 to 20 percent decrease in the circulatin
'"/>

Contact: Gerald M. Fuller, Ph.D.
gmfuller@cellbio.bhs.uab.edu
205-934-7596
Alcoholism: Clinical & Experimental Research
13-Dec-1999


Page: 1 2 3

Related biology news :

1. Moderate alcohol consumption increases plasma levels of a protective hormone
2. Moderate iron deficiency affects cognitive performance - but iron supplementation improves it
3. Moderate alcohol consumption after meals can decrease levels of insulin
4. Moderate alcohol consumption during pregnancy is risky too
5. Moderate vitamin E supplementation may lower diabetics cardiovascular risk
6. Moderate alcohol consumption increases bone mineral density in elderly women
7. Moderate caffeine use does not increase miscarriage risk but high caffeine use doubles risk
8. Duke Researchers Finds That Moderate Caffeine Use Boosts Blood Pressure, Potential For Heart Disease
9. Even Moderate Air Pollution Reaching Eastern Wilderness Decreases Mountain Hikers Lung Function
10. No Such Luck: Nitrogen From Air Pollution Unlikely to Moderate Global Warming
11. A liking for sweets, combined with novelty seeking, may predict alcoholism

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Moderate alcohol consumption may reduce your chances heart attack

(Date:5/7/2015)... 7, 2015 Fingerprint Cards ... and FPC1035, FPC,s smallest touch fingerprint sensors to ... considered for integration on the backside of the ... increased possibilities to integrate touch fingerprint sensors in ... improves possibilities for module manufacturers to customize the ...
(Date:5/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, reminds investors and media that  Mr. David Tunnell ... SECURE CONNEXIONS AMERICA 2015, held in Washington DC ... conference is organized into a series of nine session tracks. ... Fraud: Where is the Trust in Cyberspace? and will ...
(Date:4/27/2015)... , Apr. 27, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... to pre-order customers the first week of May, 2015 ... month of May. Gino Pereira ... milestone for the company as Wocket® enters the consumer ...
Breaking Biology News(10 mins):FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3
(Date:5/27/2015)... , May 26, 2015 Research and ... the "Global Breast Cancer Monoclonal Antibodies Market ... Globally, Roche seems to dominate the breast ... Its block buster molecule, Herceptin has been able ... was found that breast cancer cells become recalcitrant ...
(Date:5/27/2015)... 27, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) today ... 2015. Aviv Boim , CEO ... work to generate functional specific antibodies, targeting identified cancer ... are encouraged by the development progress. We are excited ... which modulate immune checkpoints gain clinical acceptance for cancer ...
(Date:5/27/2015)... 2015  Northwest Biotherapeutics, Inc. (NASDAQ: NWBO ) ... therapies for cancer, announced today that Dr. Marnix ... will be making an Industry Expert Theater Presentation at ... on Saturday, May 30, 2015, from 3 ... in McCormick Place. Dr. Bosch will provide ...
(Date:5/27/2015)... 2015  RXi Pharmaceuticals Corporation (NASDAQ: RXII ... developing innovative therapies primarily in the areas of ... status of the Company,s Series A and Series ... http://photos.prnewswire.com/prnh/20130917/NE80755LOGO At March ... of Series A Preferred Stock and Series A-1 ...
Breaking Biology Technology:Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 3Tikcro Technologies Reports First Quarter 2015 Results 2Tikcro Technologies Reports First Quarter 2015 Results 3NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 2NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 3RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 2RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 3
Cached News: